Explore
Validate
LearnNB100-394
antibody from Novus Biologicals
Targeting: TCF3
bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-394 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-394, RRID:AB_10001209
- Product name
- Rabbit Polyclonal TCF-3/E2A Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 ul
- Concentration
- 1.0 mg/ml
- Storage
- Store at 4C. Do not freeze.
Submitted references Accelerated Notch-dependent degradation of E47 proteins in aged B cell precursors is associated with increased ERK MAPK activation.
Positive regulation of myogenic bHLH factors and skeletal muscle development by the cell surface receptor CDO.
Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.
King AM, Van der Put E, Blomberg BB, Riley RL
Journal of immunology (Baltimore, Md. : 1950) 2007 Mar 15;178(6):3521-9
Journal of immunology (Baltimore, Md. : 1950) 2007 Mar 15;178(6):3521-9
Positive regulation of myogenic bHLH factors and skeletal muscle development by the cell surface receptor CDO.
Cole F, Zhang W, Geyra A, Kang JS, Krauss RS
Developmental cell 2004 Dec;7(6):843-54
Developmental cell 2004 Dec;7(6):843-54
Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.
Nie L, Xu M, Vladimirova A, Sun XH
The EMBO journal 2003 Nov 3;22(21):5780-92
The EMBO journal 2003 Nov 3;22(21):5780-92
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: TCF-3/E2A [p Thr355] Antibody [NB100-394] - Whole cell lysate from 293T cells that were transfected with an expression construct that encoded wild-type E2A (E47) or S352A/T355A/S359A mutant E2A (Mm). Antibody used at 0.1 ug/ml.
